Global Hereditary Angioedema Market Insights, Forecast to 2028

Report ID: 1667039 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Hereditary Angioedema Product Introduction
    1.2 Market by Type
        1.2.1 Global Hereditary Angioedema Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 C1 Esterase Inhibitor
        1.2.3 Kallikrein Inhibitor
        1.2.4 Selective Bradykinin B2 Receptor Antagonist
    1.3 Market by Distribution Channel
        1.3.1 Global Hereditary Angioedema Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028
        1.3.2 Retail Pharmacies
        1.3.3 Hospital Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Hereditary Angioedema Sales Estimates and Forecasts 2017-2028
    2.2 Global Hereditary Angioedema Revenue Estimates and Forecasts 2017-2028
    2.3 Global Hereditary Angioedema Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Hereditary Angioedema Sales by Region
        2.4.1 Global Hereditary Angioedema Sales by Region (2017-2022)
        2.4.2 Global Sales Hereditary Angioedema by Region (2023-2028)
    2.5 Global Hereditary Angioedema Revenue by Region
        2.5.1 Global Hereditary Angioedema Revenue by Region (2017-2022)
        2.5.2 Global Hereditary Angioedema Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Hereditary Angioedema Sales by Manufacturers
        3.1.1 Global Top Hereditary Angioedema Manufacturers by Sales (2017-2022)
        3.1.2 Global Hereditary Angioedema Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hereditary Angioedema in 2021
    3.2 Global Hereditary Angioedema Revenue by Manufacturers
        3.2.1 Global Hereditary Angioedema Revenue by Manufacturers (2017-2022)
        3.2.2 Global Hereditary Angioedema Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Hereditary Angioedema Revenue in 2021
    3.3 Global Hereditary Angioedema Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Hereditary Angioedema Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Hereditary Angioedema Sales by Type
        4.1.1 Global Hereditary Angioedema Historical Sales by Type (2017-2022)
        4.1.2 Global Hereditary Angioedema Forecasted Sales by Type (2023-2028)
        4.1.3 Global Hereditary Angioedema Sales Market Share by Type (2017-2028)
    4.2 Global Hereditary Angioedema Revenue by Type
        4.2.1 Global Hereditary Angioedema Historical Revenue by Type (2017-2022)
        4.2.2 Global Hereditary Angioedema Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Hereditary Angioedema Revenue Market Share by Type (2017-2028)
    4.3 Global Hereditary Angioedema Price by Type
        4.3.1 Global Hereditary Angioedema Price by Type (2017-2022)
        4.3.2 Global Hereditary Angioedema Price Forecast by Type (2023-2028)
5 Market Size by Distribution Channel
    5.1 Global Hereditary Angioedema Sales by Distribution Channel
        5.1.1 Global Hereditary Angioedema Historical Sales by Distribution Channel (2017-2022)
        5.1.2 Global Hereditary Angioedema Forecasted Sales by Distribution Channel (2023-2028)
        5.1.3 Global Hereditary Angioedema Sales Market Share by Distribution Channel (2017-2028)
    5.2 Global Hereditary Angioedema Revenue by Distribution Channel
        5.2.1 Global Hereditary Angioedema Historical Revenue by Distribution Channel (2017-2022)
        5.2.2 Global Hereditary Angioedema Forecasted Revenue by Distribution Channel (2023-2028)
        5.2.3 Global Hereditary Angioedema Revenue Market Share by Distribution Channel (2017-2028)
    5.3 Global Hereditary Angioedema Price by Distribution Channel
        5.3.1 Global Hereditary Angioedema Price by Distribution Channel (2017-2022)
        5.3.2 Global Hereditary Angioedema Price Forecast by Distribution Channel (2023-2028)
6 North America
    6.1 North America Hereditary Angioedema Market Size by Type
        6.1.1 North America Hereditary Angioedema Sales by Type (2017-2028)
        6.1.2 North America Hereditary Angioedema Revenue by Type (2017-2028)
    6.2 North America Hereditary Angioedema Market Size by Distribution Channel
        6.2.1 North America Hereditary Angioedema Sales by Distribution Channel (2017-2028)
        6.2.2 North America Hereditary Angioedema Revenue by Distribution Channel (2017-2028)
    6.3 North America Hereditary Angioedema Market Size by Country
        6.3.1 North America Hereditary Angioedema Sales by Country (2017-2028)
        6.3.2 North America Hereditary Angioedema Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Hereditary Angioedema Market Size by Type
        7.1.1 Europe Hereditary Angioedema Sales by Type (2017-2028)
        7.1.2 Europe Hereditary Angioedema Revenue by Type (2017-2028)
    7.2 Europe Hereditary Angioedema Market Size by Distribution Channel
        7.2.1 Europe Hereditary Angioedema Sales by Distribution Channel (2017-2028)
        7.2.2 Europe Hereditary Angioedema Revenue by Distribution Channel (2017-2028)
    7.3 Europe Hereditary Angioedema Market Size by Country
        7.3.1 Europe Hereditary Angioedema Sales by Country (2017-2028)
        7.3.2 Europe Hereditary Angioedema Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Hereditary Angioedema Market Size by Type
        8.1.1 Asia Pacific Hereditary Angioedema Sales by Type (2017-2028)
        8.1.2 Asia Pacific Hereditary Angioedema Revenue by Type (2017-2028)
    8.2 Asia Pacific Hereditary Angioedema Market Size by Distribution Channel
        8.2.1 Asia Pacific Hereditary Angioedema Sales by Distribution Channel (2017-2028)
        8.2.2 Asia Pacific Hereditary Angioedema Revenue by Distribution Channel (2017-2028)
    8.3 Asia Pacific Hereditary Angioedema Market Size by Region
        8.3.1 Asia Pacific Hereditary Angioedema Sales by Region (2017-2028)
        8.3.2 Asia Pacific Hereditary Angioedema Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Hereditary Angioedema Market Size by Type
        9.1.1 Latin America Hereditary Angioedema Sales by Type (2017-2028)
        9.1.2 Latin America Hereditary Angioedema Revenue by Type (2017-2028)
    9.2 Latin America Hereditary Angioedema Market Size by Distribution Channel
        9.2.1 Latin America Hereditary Angioedema Sales by Distribution Channel (2017-2028)
        9.2.2 Latin America Hereditary Angioedema Revenue by Distribution Channel (2017-2028)
    9.3 Latin America Hereditary Angioedema Market Size by Country
        9.3.1 Latin America Hereditary Angioedema Sales by Country (2017-2028)
        9.3.2 Latin America Hereditary Angioedema Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Hereditary Angioedema Market Size by Type
        10.1.1 Middle East and Africa Hereditary Angioedema Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Hereditary Angioedema Revenue by Type (2017-2028)
    10.2 Middle East and Africa Hereditary Angioedema Market Size by Distribution Channel
        10.2.1 Middle East and Africa Hereditary Angioedema Sales by Distribution Channel (2017-2028)
        10.2.2 Middle East and Africa Hereditary Angioedema Revenue by Distribution Channel (2017-2028)
    10.3 Middle East and Africa Hereditary Angioedema Market Size by Country
        10.3.1 Middle East and Africa Hereditary Angioedema Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Hereditary Angioedema Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Pharming Group NV
        11.1.1 Pharming Group NV Corporation Information
        11.1.2 Pharming Group NV Overview
        11.1.3 Pharming Group NV Hereditary Angioedema Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Pharming Group NV Hereditary Angioedema Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Pharming Group NV Recent Developments
    11.2 Takeda
        11.2.1 Takeda Corporation Information
        11.2.2 Takeda Overview
        11.2.3 Takeda Hereditary Angioedema Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Takeda Hereditary Angioedema Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Takeda Recent Developments
    11.3 CSL Limited
        11.3.1 CSL Limited Corporation Information
        11.3.2 CSL Limited Overview
        11.3.3 CSL Limited Hereditary Angioedema Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 CSL Limited Hereditary Angioedema Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 CSL Limited Recent Developments
    11.4 iBio Inc.
        11.4.1 iBio Inc. Corporation Information
        11.4.2 iBio Inc. Overview
        11.4.3 iBio Inc. Hereditary Angioedema Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 iBio Inc. Hereditary Angioedema Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 iBio Inc. Recent Developments
    11.5 BioCryst Pharmaceuticals, Inc.
        11.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information
        11.5.2 BioCryst Pharmaceuticals, Inc. Overview
        11.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 BioCryst Pharmaceuticals, Inc. Recent Developments
    11.6 Ionis Pharmaceuticals, Inc.
        11.6.1 Ionis Pharmaceuticals, Inc. Corporation Information
        11.6.2 Ionis Pharmaceuticals, Inc. Overview
        11.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Ionis Pharmaceuticals, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Hereditary Angioedema Industry Chain Analysis
    12.2 Hereditary Angioedema Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Hereditary Angioedema Production Mode & Process
    12.4 Hereditary Angioedema Sales and Marketing
        12.4.1 Hereditary Angioedema Sales Channels
        12.4.2 Hereditary Angioedema Distributors
    12.5 Hereditary Angioedema Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Hereditary Angioedema Industry Trends
    13.2 Hereditary Angioedema Market Drivers
    13.3 Hereditary Angioedema Market Challenges
    13.4 Hereditary Angioedema Market Restraints
14 Key Findings in The Global Hereditary Angioedema Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Hereditary Angioedema Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of C1 Esterase Inhibitor
    Table 3. Major Manufacturers of Kallikrein Inhibitor
    Table 4. Major Manufacturers of Selective Bradykinin B2 Receptor Antagonist
    Table 5. Global Hereditary Angioedema Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Hereditary Angioedema Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Hereditary Angioedema Sales by Region (2017-2022) & (MT)
    Table 8. Global Hereditary Angioedema Sales Market Share by Region (2017-2022)
    Table 9. Global Hereditary Angioedema Sales by Region (2023-2028) & (MT)
    Table 10. Global Hereditary Angioedema Sales Market Share by Region (2023-2028)
    Table 11. Global Hereditary Angioedema Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Hereditary Angioedema Revenue Market Share by Region (2017-2022)
    Table 13. Global Hereditary Angioedema Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Hereditary Angioedema Revenue Market Share by Region (2023-2028)
    Table 15. Global Hereditary Angioedema Sales by Manufacturers (2017-2022) & (MT)
    Table 16. Global Hereditary Angioedema Sales Share by Manufacturers (2017-2022)
    Table 17. Global Hereditary Angioedema Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Hereditary Angioedema Revenue Share by Manufacturers (2017-2022)
    Table 19. Hereditary Angioedema Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 20. Global Hereditary Angioedema Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Hereditary Angioedema by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema as of 2021)
    Table 22. Hereditary Angioedema Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Hereditary Angioedema Product Offered
    Table 24. Date of Manufacturers Enter into Hereditary Angioedema Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Hereditary Angioedema Sales by Type (2017-2022) & (MT)
    Table 27. Global Hereditary Angioedema Sales by Type (2023-2028) & (MT)
    Table 28. Global Hereditary Angioedema Sales Share by Type (2017-2022)
    Table 29. Global Hereditary Angioedema Sales Share by Type (2023-2028)
    Table 30. Global Hereditary Angioedema Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Hereditary Angioedema Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Hereditary Angioedema Revenue Share by Type (2017-2022)
    Table 33. Global Hereditary Angioedema Revenue Share by Type (2023-2028)
    Table 34. Hereditary Angioedema Price by Type (2017-2022) & (USD/Kg)
    Table 35. Global Hereditary Angioedema Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 36. Global Hereditary Angioedema Sales by Distribution Channel (2017-2022) & (MT)
    Table 37. Global Hereditary Angioedema Sales by Distribution Channel (2023-2028) & (MT)
    Table 38. Global Hereditary Angioedema Sales Share by Distribution Channel (2017-2022)
    Table 39. Global Hereditary Angioedema Sales Share by Distribution Channel (2023-2028)
    Table 40. Global Hereditary Angioedema Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 41. Global Hereditary Angioedema Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 42. Global Hereditary Angioedema Revenue Share by Distribution Channel (2017-2022)
    Table 43. Global Hereditary Angioedema Revenue Share by Distribution Channel (2023-2028)
    Table 44. Hereditary Angioedema Price by Distribution Channel (2017-2022) & (USD/Kg)
    Table 45. Global Hereditary Angioedema Price Forecast by Distribution Channel (2023-2028) & (USD/Kg)
    Table 46. North America Hereditary Angioedema Sales by Type (2017-2022) & (MT)
    Table 47. North America Hereditary Angioedema Sales by Type (2023-2028) & (MT)
    Table 48. North America Hereditary Angioedema Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Hereditary Angioedema Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Hereditary Angioedema Sales by Distribution Channel (2017-2022) & (MT)
    Table 51. North America Hereditary Angioedema Sales by Distribution Channel (2023-2028) & (MT)
    Table 52. North America Hereditary Angioedema Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 53. North America Hereditary Angioedema Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 54. North America Hereditary Angioedema Sales by Country (2017-2022) & (MT)
    Table 55. North America Hereditary Angioedema Sales by Country (2023-2028) & (MT)
    Table 56. North America Hereditary Angioedema Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Hereditary Angioedema Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Hereditary Angioedema Sales by Type (2017-2022) & (MT)
    Table 59. Europe Hereditary Angioedema Sales by Type (2023-2028) & (MT)
    Table 60. Europe Hereditary Angioedema Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Hereditary Angioedema Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Hereditary Angioedema Sales by Distribution Channel (2017-2022) & (MT)
    Table 63. Europe Hereditary Angioedema Sales by Distribution Channel (2023-2028) & (MT)
    Table 64. Europe Hereditary Angioedema Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 65. Europe Hereditary Angioedema Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 66. Europe Hereditary Angioedema Sales by Country (2017-2022) & (MT)
    Table 67. Europe Hereditary Angioedema Sales by Country (2023-2028) & (MT)
    Table 68. Europe Hereditary Angioedema Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Hereditary Angioedema Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Hereditary Angioedema Sales by Type (2017-2022) & (MT)
    Table 71. Asia Pacific Hereditary Angioedema Sales by Type (2023-2028) & (MT)
    Table 72. Asia Pacific Hereditary Angioedema Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Hereditary Angioedema Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Hereditary Angioedema Sales by Distribution Channel (2017-2022) & (MT)
    Table 75. Asia Pacific Hereditary Angioedema Sales by Distribution Channel (2023-2028) & (MT)
    Table 76. Asia Pacific Hereditary Angioedema Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Hereditary Angioedema Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Hereditary Angioedema Sales by Region (2017-2022) & (MT)
    Table 79. Asia Pacific Hereditary Angioedema Sales by Region (2023-2028) & (MT)
    Table 80. Asia Pacific Hereditary Angioedema Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Hereditary Angioedema Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Hereditary Angioedema Sales by Type (2017-2022) & (MT)
    Table 83. Latin America Hereditary Angioedema Sales by Type (2023-2028) & (MT)
    Table 84. Latin America Hereditary Angioedema Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Hereditary Angioedema Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Hereditary Angioedema Sales by Distribution Channel (2017-2022) & (MT)
    Table 87. Latin America Hereditary Angioedema Sales by Distribution Channel (2023-2028) & (MT)
    Table 88. Latin America Hereditary Angioedema Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 89. Latin America Hereditary Angioedema Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 90. Latin America Hereditary Angioedema Sales by Country (2017-2022) & (MT)
    Table 91. Latin America Hereditary Angioedema Sales by Country (2023-2028) & (MT)
    Table 92. Latin America Hereditary Angioedema Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Hereditary Angioedema Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Hereditary Angioedema Sales by Type (2017-2022) & (MT)
    Table 95. Middle East and Africa Hereditary Angioedema Sales by Type (2023-2028) & (MT)
    Table 96. Middle East and Africa Hereditary Angioedema Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Hereditary Angioedema Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Hereditary Angioedema Sales by Distribution Channel (2017-2022) & (MT)
    Table 99. Middle East and Africa Hereditary Angioedema Sales by Distribution Channel (2023-2028) & (MT)
    Table 100. Middle East and Africa Hereditary Angioedema Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Hereditary Angioedema Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Hereditary Angioedema Sales by Country (2017-2022) & (MT)
    Table 103. Middle East and Africa Hereditary Angioedema Sales by Country (2023-2028) & (MT)
    Table 104. Middle East and Africa Hereditary Angioedema Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Hereditary Angioedema Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Pharming Group NV Corporation Information
    Table 107. Pharming Group NV Description and Major Businesses
    Table 108. Pharming Group NV Hereditary Angioedema Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 109. Pharming Group NV Hereditary Angioedema Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Pharming Group NV Recent Developments
    Table 111. Takeda Corporation Information
    Table 112. Takeda Description and Major Businesses
    Table 113. Takeda Hereditary Angioedema Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 114. Takeda Hereditary Angioedema Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Takeda Recent Developments
    Table 116. CSL Limited Corporation Information
    Table 117. CSL Limited Description and Major Businesses
    Table 118. CSL Limited Hereditary Angioedema Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 119. CSL Limited Hereditary Angioedema Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. CSL Limited Recent Developments
    Table 121. iBio Inc. Corporation Information
    Table 122. iBio Inc. Description and Major Businesses
    Table 123. iBio Inc. Hereditary Angioedema Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 124. iBio Inc. Hereditary Angioedema Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. iBio Inc. Recent Developments
    Table 126. BioCryst Pharmaceuticals, Inc. Corporation Information
    Table 127. BioCryst Pharmaceuticals, Inc. Description and Major Businesses
    Table 128. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 129. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. BioCryst Pharmaceuticals, Inc. Recent Developments
    Table 131. Ionis Pharmaceuticals, Inc. Corporation Information
    Table 132. Ionis Pharmaceuticals, Inc. Description and Major Businesses
    Table 133. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 134. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Ionis Pharmaceuticals, Inc. Recent Developments
    Table 136. Key Raw Materials Lists
    Table 137. Raw Materials Key Suppliers Lists
    Table 138. Hereditary Angioedema Distributors List
    Table 139. Hereditary Angioedema Customers List
    Table 140. Hereditary Angioedema Market Trends
    Table 141. Hereditary Angioedema Market Drivers
    Table 142. Hereditary Angioedema Market Challenges
    Table 143. Hereditary Angioedema Market Restraints
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hereditary Angioedema Product Picture
    Figure 3. Global Hereditary Angioedema Market Share by Type in 2021 & 2028
    Figure 3. C1 Esterase Inhibitor Product Picture
    Figure 4. Kallikrein Inhibitor Product Picture
    Figure 5. Selective Bradykinin B2 Receptor Antagonist Product Picture
    Figure 6. Global Hereditary Angioedema Market Share by Distribution Channel in 2021 & 2028
    Figure 7. Retail Pharmacies
    Figure 8. Hospital Pharmacies
    Figure 9. Online Pharmacies
    Figure 10. Hereditary Angioedema Report Years Considered
    Figure 11. Global Hereditary Angioedema Sales 2017-2028 (MT)
    Figure 12. Global Hereditary Angioedema Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Hereditary Angioedema Revenue 2017-2028 (US$ Million)
    Figure 14. Global Hereditary Angioedema Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Hereditary Angioedema Sales Market Share by Region (2017-2022)
    Figure 16. Global Hereditary Angioedema Sales Market Share by Region (2023-2028)
    Figure 17. North America Hereditary Angioedema Sales YoY (2017-2028) & (MT)
    Figure 18. North America Hereditary Angioedema Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Hereditary Angioedema Sales YoY (2017-2028) & (MT)
    Figure 20. Europe Hereditary Angioedema Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Hereditary Angioedema Sales YoY (2017-2028) & (MT)
    Figure 22. Asia-Pacific Hereditary Angioedema Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Hereditary Angioedema Sales YoY (2017-2028) & (MT)
    Figure 24. Latin America Hereditary Angioedema Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Hereditary Angioedema Sales YoY (2017-2028) & (MT)
    Figure 26. Middle East & Africa Hereditary Angioedema Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Hereditary Angioedema Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Hereditary Angioedema in the World: Market Share by Hereditary Angioedema Revenue in 2021
    Figure 29. Global Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Hereditary Angioedema Sales Market Share by Type (2017-2028)
    Figure 31. Global Hereditary Angioedema Revenue Market Share by Type (2017-2028)
    Figure 32. Global Hereditary Angioedema Sales Market Share by Distribution Channel (2017-2028)
    Figure 33. Global Hereditary Angioedema Revenue Market Share by Distribution Channel (2017-2028)
    Figure 34. North America Hereditary Angioedema Sales Market Share by Type (2017-2028)
    Figure 35. North America Hereditary Angioedema Revenue Market Share by Type (2017-2028)
    Figure 36. North America Hereditary Angioedema Sales Market Share by Distribution Channel (2017-2028)
    Figure 37. North America Hereditary Angioedema Revenue Market Share by Distribution Channel (2017-2028)
    Figure 38. North America Hereditary Angioedema Sales Share by Country (2017-2028)
    Figure 39. North America Hereditary Angioedema Revenue Share by Country (2017-2028)
    Figure 40. U.S. Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Hereditary Angioedema Sales Market Share by Type (2017-2028)
    Figure 43. Europe Hereditary Angioedema Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Hereditary Angioedema Sales Market Share by Distribution Channel (2017-2028)
    Figure 45. Europe Hereditary Angioedema Revenue Market Share by Distribution Channel (2017-2028)
    Figure 46. Europe Hereditary Angioedema Sales Share by Country (2017-2028)
    Figure 47. Europe Hereditary Angioedema Revenue Share by Country (2017-2028)
    Figure 48. Germany Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 49. France Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Hereditary Angioedema Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Hereditary Angioedema Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Hereditary Angioedema Sales Market Share by Distribution Channel (2017-2028)
    Figure 56. Asia Pacific Hereditary Angioedema Revenue Market Share by Distribution Channel (2017-2028)
    Figure 57. Asia Pacific Hereditary Angioedema Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Hereditary Angioedema Revenue Share by Region (2017-2028)
    Figure 59. China Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 62. India Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Hereditary Angioedema Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Hereditary Angioedema Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Hereditary Angioedema Sales Market Share by Distribution Channel (2017-2028)
    Figure 72. Latin America Hereditary Angioedema Revenue Market Share by Distribution Channel (2017-2028)
    Figure 73. Latin America Hereditary Angioedema Sales Share by Country (2017-2028)
    Figure 74. Latin America Hereditary Angioedema Revenue Share by Country (2017-2028)
    Figure 75. Mexico Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Hereditary Angioedema Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Hereditary Angioedema Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Hereditary Angioedema Sales Market Share by Distribution Channel (2017-2028)
    Figure 81. Middle East and Africa Hereditary Angioedema Revenue Market Share by Distribution Channel (2017-2028)
    Figure 82. Middle East and Africa Hereditary Angioedema Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Hereditary Angioedema Revenue Share by Country (2017-2028)
    Figure 84. Turkey Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Hereditary Angioedema Revenue (2017-2028) & (US$ Million)
    Figure 87. Hereditary Angioedema Value Chain
    Figure 88. Hereditary Angioedema Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pharming Group NV
Takeda
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Frequently Asked Questions
Hereditary Angioedema report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hereditary Angioedema report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hereditary Angioedema report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hexachlorodisilane

Hexachlorodisilane market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More